Sea Crest Wealth Management, LLC Abiomed Inc Transaction History

Sea Crest Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$224.73 - $338.64 $8,989 - $13,545	40 Added 5.8%	730 $181,000
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $11,090 - $14,651	40 Added 6.15%	690 $229,000
Q2 2021 Aug 12, 2021	SELL	$262.71 - $351.17 $3,415 - $4,565	-13 Reduced 1.96%	650 $203,000
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $2,001 - $2,485	-7 Reduced 1.04%	663 $211,000
Q4 2020 Feb 09, 2021	BUY	$251.88 - $324.2 $168,759 - $217,214	670 New	670 $217,000
Q2 2019 Jul 19, 2019	SELL	$250.96 - $284.94 $139,282 - $158,141	-555 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$281.08 - $444.25 $34,572 - $54,642	-123 Reduced 18.14%	555 $180,000
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $87,568 - $111,088	-247 Reduced 26.7%	678 $305,000
Q2 2018 Aug 03, 2018	SELL	$278.07 - $446.21 $13,903 - $22,310	-50 Reduced 5.13%	925 $378,000
Q4 2017 Feb 02, 2018	BUY	$168.78 - $199.74 $164,560 - $194,746	975	975 $183,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.